D-0787-2026 Class I Ongoing
FDA drug recall D-0787-2026 was initiated by Baxter Healthcare Corporation on July 24, 2026 and is designated Class I. Reason for recall: Presence of Particulate Matter The recall status is ongoing. Affected quantity: 19,032 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- August 19, 2026
- Initiation Date
- July 24, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,032 bags
Product Description
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Reason for Recall
Presence of Particulate Matter
Distribution Pattern
US Nationwide.
Code Information
Lot # LD175708, Exp Date: 14-Feb-2027.